Table IV.
Status of evaluation for stillbirth
| Generally accepted tests: |
| Fetal autopsy |
| Placental evaluation |
| Karyotype |
| Indirect Coombs’ |
| Serologic test for syphilis |
| Screen for fetal-maternal hemorrhage (Kliehauer-Betke or other) |
| Toxicology screen |
| Thorough medical and obstetric history |
| Parvovirus serology |
| Useful in some cases: |
| Lupus anticoagulant screen |
| Anticardiolipin antibodies |
| Factor V Leiden mutation |
| Prothrombin G20210A mutation |
| Screen for protein C, protein S, and antithrombin III deficiency |
| Uncertain utility: |
| TSH |
| Glycohemoglobin |
| TORCH titers |
| Placental cultures |
| Testing for other thrombophilias |
| Developing technology: |
| Comparative genomic hybridization |
| Testing for single gene mutations |
| Testing for confined placental mosaicism |
| Nucleic acid based testing for infection |